Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy( )

BACKGROUND: Systemic drug reaction (SDR) is a major safety concern with weekly rifapentine plus isoniazid for 12 doses (3HP) for latent tuberculosis infection (LTBI). Identifying SDR predictors and at-risk participants before treatment can improve cost-effectiveness of the LTBI program. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hung Ling, Lee, Jung Yu, Lo, Yu Shu, Liu, I Hsin, Huang, Sing Han, Huang, Yu Wei, Lee, Meng Rui, Lee, Chih Hsin, Cheng, Meng Hsuan, Lu, Po Liang, Wang, Jann Yuan, Yang, Jinn Moon, Chong, Inn Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477448/
https://www.ncbi.nlm.nih.gov/pubmed/34989801
http://dx.doi.org/10.1093/cid/ciac003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477448/
https://www.ncbi.nlm.nih.gov/pubmed/34989801
http://dx.doi.org/10.1093/cid/ciac003

Ejemplares similares